Scientific Publications by FDA Staff
J Environ Sci Health A 2014;49(6):641-7
Synthesis and cytotoxicity studies of Hedgehog enzyme inhibitors SANT-1 and GANT-61 as anticancer agents.
Chenna V, Hu C, Khan SR
Cancer-related death is one of the most common causes of mortality in society. Small molecules have the capability to disrupt aberrant signaling pathways in tumors, leading to anticancer activities. Therefore the search for new molecules for cancer treatment continues to draw attention to the scientific research community. Synthesis and biological evaluation of hedgehog (Hh) pathway inhibitors SANT-1 and GANT-61 are disclosed. These molecules have been synthesized from common precursors using simple conversions, our synthesis features Vils-Meier-Haack reaction, imine formation reaction and N-arylation reaction. These drugs were evaluated using a Hh reporter assay to confirm pathway inhibitory activity, and tested for cell viability against pancreatic and prostate cancer cells. These methodologies can be applied to make potent analogs of both inhibitors.
|Category: Journal Article|
|PubMed ID: #24521409||DOI: 10.1080/10934529.2014.865425|
|Includes FDA Authors from Scientific Area(s): Drugs|
|Entry Created: 2014-03-30||Entry Last Modified: 2015-06-04|